<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Paxlovid efficacy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/paxlovid-efficacy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 13:38:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Paxlovid efficacy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Extended Paxlovid Treatment Shows Promise for Alleviating Long COVID Symptoms in Certain Patients</title>
		<link>https://bioengineer.org/extended-paxlovid-treatment-shows-promise-for-alleviating-long-covid-symptoms-in-certain-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 06 Jan 2025 10:21:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antiviral therapy research]]></category>
		<category><![CDATA[Long COVID treatment]]></category>
		<category><![CDATA[patient-led research collaboration]]></category>
		<category><![CDATA[Paxlovid efficacy]]></category>
		<category><![CDATA[UCSF clinical trials]]></category>
		<guid isPermaLink="false">https://bioengineer.org/extended-paxlovid-treatment-shows-promise-for-alleviating-long-covid-symptoms-in-certain-patients/</guid>

					<description><![CDATA[Long Covid has been recognized as a complex condition which affects a considerable portion of the population, with estimates from the Centers for Disease Control and Prevention (CDC) suggesting that approximately 17.6 million Americans, or about one in 13 adults, are grappling with this multifaceted syndrome. The symptoms of long Covid can vary greatly in [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">233089</post-id>	</item>
	</channel>
</rss>
